The Mesothelioma Center News – Page 22
-
news
Research & Clinical TrialsResearchers have made significant progress in mesothelioma treatment advancements recently, including promising work with immunotherapy. The first U.S. Food and Drug Administration-approved combination… -
news
Research & Clinical TrialsMesothelioma Clinical Trial to Involve Drug Studied for COVID-19
A novel phase II clinical trial for malignant mesothelioma is expected to open soon and involve a versatile, biological drug already showing promise… -
news
Legislation & LitigationCourt Deals Blow to Johnson & Johnson Bankruptcy Plan for Talc Cases
A federal judge in North Carolina delivered a major setback to Johnson & Johnson and its controversial plan to unload all talc-related… -
news
Research & Clinical TrialsUniversity of Vermont Study Opens New Door for Mesothelioma Treatment
Researchers at the University of Vermont Cancer Center have uncovered a new approach to the treatment of malignant pleural mesothelioma, sparking a… -
news
Research & Clinical TrialsStudy Supports Opdivo as Second-Line Mesothelioma Treatment
When the effectiveness of first-line chemotherapy fails and malignant mesothelioma returns, more patients could soon turn with confidence to a proven, second-line… -
news
Legislation & LitigationNew California Law Could Benefit Mesothelioma Plaintiffs
A recently amended California law will now allow the estates of deceased plaintiffs, including mesothelioma patients, to collect pain and suffering damages. -
news
Legislation & LitigationJohnson & Johnson Sending Talc Cases to Bankruptcy Court
As expected, Johnson & Johnson has unloaded its burgeoning talc-related liabilities on a new subsidiary that filed for Chapter 11 bankruptcy protection on… -
news
Legislation & LitigationCourts Seeing More Secondary Asbestos Exposure Lawsuits
Secondary exposure to toxic asbestos has declined considerably in recent decades, but known cases of malignant mesothelioma caused by that type of… -
news
Legislation & LitigationEPA Settles Lawsuits, Agrees to Broader Asbestos Risk Evaluations
Facing legal pressure from health and advocacy organizations, the U.S. Environmental Protection Agency has agreed to broaden its ongoing Risk Evaluation for Asbestos under… -
news
Research & Clinical TrialsResearchers Open Phase I Clinical Trial of Cryoablation with Keytruda
Memorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with…